EX-23.1 2 ea023533701ex23-1_silophar.htm CONSENT OF SALBERG & COMPANY, P.A

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the use of our report dated March 28, 2025, on the consolidated financial statements of Silo Pharma, Inc. as of and for the years ended December 31, 2024 and 2023, included herein in the post-effective registration statement of Silo Pharma, Inc. on Form S-1,. and to the reference to our firm under the heading “Experts” in the prospectus.

 

/s/ Salberg & Company, P.A.

 

SALBERG & COMPANY, P.A.

Boca Raton, Florida

March 28, 2025

 

2295 NW Corporate Blvd., Suite 240 ● Boca Raton, FL 33431-7328

Phone: (561) 995-8270 ● Toll Free: (866) CPA-8500 ● Fax: (561) 995-1920

www.salbergco.com ● info@salbergco.com

Member National Association of Certified Valuation Analysts ● Registered with the PCAOB

Member CPAConnect with Affiliated Offices Worldwide ● Member AICPA Center for Audit Quality